MNEXSPIKE 2026-2027 vaccine, 0.2 mL Prefilled Syringe
RxNorm 2750230

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2750230 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: mNEXSPIKE 2026-2027 vaccine, 0.2 mL Prefilled Syringe.

The following semantic concepts and normalized strings are associated with this clinical entity:

SY
0.2 mL Mnexspike 2026-2027 0.05 mg/ML Prefilled Syringe
AUI:13080515
SBD
0.2 mL SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 XFG (JN.1) 0.05 mg/ML Prefilled Syringe [Mnexspike 2026-2027]
AUI:13080514
PSN
MNEXSPIKE 2026-2027 vaccine, 0.2 mL Prefilled Syringe
AUI:13080519
SY
MNEXSPIKE 2026-2027 vaccine, 0.2 mL Prefilled Syringe
AUI:13080518

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SYPrescribable

Synonym (SY):
0.2 mL Mnexspike 2026-2027 0.05 mg/ML Prefilled Syringe
(Atom ID: 13080515)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
0.2 ML Mnexspike 2026-2027 0.05 MG/ML Prefilled Syringe
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2750230
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
13080515
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
2750230
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_261102F
The specific version of the vocabulary provided by the source.
Update Date
November 02, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

SBDPrescribable

Semantic Branded Drug (SBD):
0.2 mL SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 XFG (JN.1) 0.05 mg/ML Prefilled Syringe [Mnexspike 2026-2027]
(Atom ID: 13080514)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
0.2 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 XFG (JN.1) 0.05 MG/ML Prefilled Syringe [Mnexspike 2026-2027]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2750230
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
13080514
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
2750230
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_261102F
The specific version of the vocabulary provided by the source.
Update Date
November 02, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{2750220} 2750219
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{2750220} 2750219
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH
0.05 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 XFG (JN.1))
Available drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM
{2750220} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUG
US
Drug available for use in Humans
RXN QUANTITY
0.2 ML
Normal Form quantity factor
RXTERM FORM
Prefilled Syringe
The RxTerm dose form name for this drug

PSNPrescribable

Prescribable Name (PSN):
MNEXSPIKE 2026-2027 vaccine, 0.2 mL Prefilled Syringe
(Atom ID: 13080519)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
mNEXSPIKE 2026-2027 vaccine, 0.2 ML Prefilled Syringe
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2750230
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
13080519
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
2750230
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_261102F
The specific version of the vocabulary provided by the source.
Update Date
November 02, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

SYPrescribable

Synonym (SY):
MNEXSPIKE 2026-2027 vaccine, 0.2 mL Prefilled Syringe
(Atom ID: 13080518)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
mNEXSPIKE 2026-2027 vaccine, 0.2 ML Prefilled Syringe
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2750230
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
13080518
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
2750230
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_261102F
The specific version of the vocabulary provided by the source.
Update Date
November 02, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.